IOVA Iovance Biotherapeutics, Inc.

NEUTRAL Impact: 2/10 PRESS-RELEASE
Horizon immediate Filed May 22, 2026 Processed 21d 15h ago Wire GlobeNewswire
Press release: announcement
Latest settled — T+5d
IOVA ▼ -3.41% at T+5d
NEUTRAL call ✗ call lost -3.41% · α vs SPY -4.50% · entry $4.10 → $3.96
Next anchor: T+20d in 10d
Currently $4.08 · -0.49% from $4.10 entry
Entry anchored
May 22, 03:59 PM ET
via Databento tick
T+1d
+8.05%
call +8.05% · α +8.09%
$4.43
settled 18d ago
T+5d
-3.41%
call -3.41% · α -4.50%
$3.96
settled 12d ago
T+20d
call — · α —
in 10d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Iovance Biotherapeutics granted inducement stock options covering 93,340 shares to 13 new non-executive employees under its 2021 Inducement Plan. The options have an exercise price of $3.70 and vest over three years. This is a routine equity grant for new hires, not a material financial event.

Actionable Insight

Routine new-hire equity grant — no trading signal. Monitor upcoming quarterly results for commercial progress on Amtagvi and pipeline updates.

Key Facts

  • 93,340 shares of common stock granted as inducement stock options to 13 new non-executive employees.
  • Exercise price of $3.70, equal to the closing price on the grant date (May 21, 2026).
  • Options vest over three years: one-third on first anniversary, remainder in quarterly installments.
  • Granted under the Amended and Restated 2021 Inducement Plan per Nasdaq Listing Rule 5635(c)(4).

Financial Impact

93,340 shares at $3.70 per share = approximately $345,000 in potential option value; immaterial relative to Iovance's $1.7B market cap.

dilution

Risk Factors

  • No material risk from this grant; dilution is negligible.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
76% bullish (17 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3300384
5 reports for IOVA
Performance horizon
Filters
Rows
Reports for IOVA — sortable, filterable
Type Now
Jun 10, 2026
2d ago
8-K
BULLISH ★ 7/10
$3.77 awaiting T+5awaiting T+5$4.08 (+8.22%)
May 22, 2026
21d ago
Press Release
NEUTRAL ★ 2/10
$4.10 $3.96▼ −3.41%▼ −4.50%$4.08 (−0.49%)
Apr 28, 2026
6w ago
DEFA14A
NEUTRAL ★ 3/10
$3.31 $4.09▲ +23.57%▲ +20.45%$4.08 (+23.26%)
Apr 27, 2026
6w ago
Press Release
NEUTRAL ★ 3/10
$3.43 $3.85▲ +12.24%▲ +11.84%$4.08 (+18.95%)
Apr 17, 2026
8w ago
Press Release
NEUTRAL ★ 2/10
$3.78 $3.43▼ −9.26%▼ −10.17%$4.08 (+7.94%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (48h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access